Drug Profile


Alternative Names: A 73001; AA 2414; Abbott 73001; ABT 001; Bronica; Serabenast

Latest Information Update: 12 Oct 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Takeda
  • Class Antiallergics; Antiasthmatics; Benzoquinones; Heptanoic acids; Small molecules
  • Mechanism of Action Prostaglandin receptor antagonists; Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Asthma
  • Discontinued Allergic rhinitis; Chronic obstructive pulmonary disease

Most Recent Events

  • 12 Oct 2000 Discontinued-III for Allergic rhinitis in Japan (PO)
  • 12 Oct 2000 Discontinued-III for Asthma in Europe (PO)
  • 18 Aug 2000 A study in patients with asthma has been added to the Obstructive Airways Disease therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top